Reduced vascular endothelial growth factor expression in contusive spinal cord injury

Journal of Neurotrauma

Volumn 26, Issue 7, 2009, Pages 995-1003

  Herrera, Juan J ^a   Nesic, Olivera ^b   Narayana, Ponnada A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Contusion; Expression; Growth factor; Immunofluorescence; Isoforms; Neuroprotection; Spinal cord injury; Vascular; Western

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN 165; NEUROPROTECTIVE AGENT; RECOMBINANT PROTEIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CONTUSION; IMMUNOFLUORESCENCE; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RAT; SPINAL CORD INJURY; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; IMMUNOHISTOCHEMISTRY; METABOLISM; SPINAL CORD; SPINAL CORD INJURIES; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SPINAL CORD; SPINAL CORD INJURIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 69249108768     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2008.0779     Document Type: Article

References (40)

1. Armao, D., Kornfeld, M., Estrada, E.Y., Grossetete, M., and Rosenberg, G.A. (1997). Neutral proteases and disruption of the blood-brain barrier in rat. Brain Res. 767, 259-264. (Pubitemid 27435771)
2. Bao, W.L., Lu, S.D., Wang, H., and Sun, F.Y. (1999). Intraventricular vascular endothelial growth factor antibody increases infarct volume following transient cerebral ischemia. Zhongguo Yao Li Xue Bao 20, 313-318. (Pubitemid 29193591)
3. Benton, R.L., and Whittemore, S.R. (2003). VEGF165 therapy exacerbates secondary damage following spinal cord injury. Neurochem. Res. 28, 1693-1703.
4. Brandner, B., Kurkela, R., Vihko, P., and Kungl, A.J. (2006). Investigating the effect of VEGF glycosylation on glycosaminoglycan binding and protein unfolding. Biochem. Biophys. Res. Commun. 340, 836-839.
5. Choi, J.S., Kim, H.Y., Cha, J.H., Choi, J.Y., Park, S.I., Jeong, C.H., Jeun, S.S., and Lee, M.Y. (2007). Upregulation of vascular endothelial growth factor receptors Flt-1 and Flk-1 following acute spinal cord contusion in rats. J. Histochem. Cytochem. 55, 821-830.
6. Choi, U.H., Ha, Y., Huang, X., Park, S.R., Chung, J., Hyun, D.K., Park, H., Park, H.C., Kim, S.W., and Lee, M. (2007). Hypoxiainducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model. J. Neurosurg. Spine 7, 54-60. (Pubitemid 47067739)
7. Connolly, D.T., Olander, J.V., Heuvelman, D., Nelson, R., Monsell, R., Siegel, N., Haymore, B.L., Leimgruber, R., and Feder, J. (1989). Human vascular permeability factor. Isolation from U937 cells. J. Biol. Chem. 264, 20017-20024.
8. Facchiano, F., Fernandez, E., Mancarella, S., Maira, G., Miscusi, M., D'Arcangelo, D., Cimino-Reale, G., Falchetti, M.L., Capogrossi, M.C., and Pallini, R. (2002). Promotion of regeneration of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor. J. Neurosurg. 97, 161-168. (Pubitemid 34693714)
9. Ferrara, N., Gerber, H.P., and LeCouter, J. (2003). The biology of VEGF and its receptors. Nat. Med. 9, 669-676.
10. Figueroa, B.E., Keep, R.F., Betz, A.L., and Hoff, J.T. (1998). Plasminogen activators potentiate thrombin-induced brain injury. Stroke 29, 1202-1208.
11. Gluzman-Poltorak, Z., Cohen, T., Herzog, Y., and Neufeld, G. (2000). Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]. J. Biol. Chem. 275, 18040-18045.
12. Grossman, S.D., Rosenberg, L.J., and Wrathall, J.R. (2001). Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp. Neurol. 168, 273-282.
13. Jin, K.L., Mao, X.O., Nagayama, T., Goldsmith, P.C., and Greenberg, D.A. (2000). Induction of vascular endothelial growth factor and hypoxia-inducible factor-1alpha by global ischemia in rat brain. Neuroscience 99, 577-585. (Pubitemid 30612460)
14. Jingjing, L., Xue, Y., Agarwal, N., and Roque, R.S. (1999). Human Muller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor. Invest. Ophthalmol. Vis. Sci. 40, 752-759.
15. Lambrechts, D., Storkebaum, E., and Carmeliet, P. (2004). VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS? Trends Mol. Med. 10, 275-282. (Pubitemid 38725895)
16. Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S.L., Wyns, S., Thijs, V., Andersson, J., van Marion, I., Al-Chalabi, A., Bornes, S., Musson, R., Hansen, V., Beckman, L., Adolfsson, R., Pall, H.S., Prats, H., Vermeire, S., Rutgeerts, P., Katayama, S., Awata, T., Leigh, N., Lang-Lazdunski, L., Dewerchin, M., Shaw, C., Moons, L., Vlietinck, R., Morrison, K.E., Robberecht, W., Van Broeckhoven, C., Collen, D., Andersen, P.M., and Carmeliet, P. (2003). VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 34, 383-394.
17. Lauer, G., Sollberg, S., Cole, M., Flamme, I., Sturzebecher, J., Mann, K., Krieg, T., and Eming, S.A. (2000). Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J. Invest. Dermatol. 115, 12-18.
18. Leung, D.W., Cachianes, G., Kuang, W.J., Goeddel, D.V., and Ferrara, N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309. (Pubitemid 20066716)
19. Makinen, T., Olofsson, B., Karpanen, T., Hellman, U., Soker, S., Klagsbrun, M., Eriksson, U., and Alitalo, K. (1999). Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1. J. Biol. Chem. 274, 21217-21222.
20. Migdal, M., Huppertz, B., Tessler, S., Comforti, A., Shibuya, M., Reich, R., Baumann, H., and Neufeld, G. (1998). Neuropilin-1 is a placenta growth factor-2 receptor. J. Biol. Chem. 273, 22272-22278.
21. Nesic, O., Lee, J., Ye, Z., Unabia, G.C., Rafati, D., Hulsebosch, C.E., and Perez-Polo, J.R. (2006). Acute and chronic changes in aquaporin 4 expression after spinal cord injury. Neuroscience 143, 779-792. (Pubitemid 44751372)
22. Nesic-Taylor, O., Cittelly, D., Ye, Z., Xu, G.Y., Unabia, G., Lee, J.C., Svrakic, N.M., Liu, X.H., Youle, R.J., Wood, T.G., McAdoo, D., Westlund, K.N., Hulsebosch, C.E., and Perez-Polo, J.R. (2005). Exogenous Bcl-xL fusion protein spares neurons after spinal cord injury. J. Neurosci. Res. 79, 628-637.
23. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. (1999). Vascular endothelial growth factor (VEGF) and its receptors. Faseb J. 13, 9-22. (Pubitemid 29038270)
24. Ogunshola, O.O., Stewart, W.B., Mihalcik, V., Solli, T., Madri, J.A., and Ment, L.R. (2000). Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res. Dev. Brain Res. 119, 139-153.
25. Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Van Dorpe, J., Hellings, P., Gorselink, M., Heymans, S., Theilmeier, G., Dewerchin, M., Laudenbach, V., Vermylen, P., Raat, H., Acker, T., Vleminckx, V., Van Den Bosch, L., Cashman, N., Fujisawa, H., Drost, M.R., Sciot, R., Bruyninckx, F., Hicklin, D.J., Ince, C., Gressens, P., Lupu, F., Plate, K.H., Robberecht, W., Herbert, J.M., Collen, D., and Carmeliet, P. (2001). Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28, 131-138.
26. Park, J.E., Keller, G.A., and Ferrara, N. (1993). The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 4, 1317-1326.
27. Poltorak, Z., Cohen, T., Sivan, R., Kandelis, Y., Spira, G., Vlodavsky, I., Keshet, E., and Neufeld, G. (1997). VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J. Biol. Chem. 272, 7151-7158.
28. Ramu, J., Bockhorst, K.H., Grill, R.J., Mogatadakala, K.V., and Narayana, P.A. (2007). Cortical reorganization in NT3-treated experimental spinal cord injury: functional magnetic resonance imaging. Exp. Neurol. 204, 58-65.
29. Robinson, C.J., and Stringer, S.E. (2001). The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 114, 853-865. (Pubitemid 32273121)
30. Savas, S., Savas, C., Altuntas, I., and Adiloglu, A. (2008). The correlation between nitric oxide and vascular endothelial growth factor in spinal cord injury. Spinal Cord 46, 113-117. (Pubitemid 351220572)
31. Scheff, S.W., Rabchevsky, A.G., Fugaccia, I., Main, J.A., and Lumpp, J.E., Jr. (2003). Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J. Neurotrauma 20, 179-193.
32. Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S., and Dvorak, H.F. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985.
33. Skold, M., Cullheim, S., Hammarberg, H., Piehl, F., Suneson, A., Lake, S., Sjogren, A., Walum, E., and Risling, M. (2000). Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration. Eur. J. Neurosci. 12, 3675-3686.
34. Soker, S., Takashima, S., Miao, H.Q., Neufeld, G., and Klagsbrun, M. (1998). Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745. (Pubitemid 28155313)
35. Svensson, B., Peters, M., Konig, H.G., Poppe, M., Levkau, B., Rothermundt, M., Arolt, V., Kogel, D., and Prehn, J.H. (2002). Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. J. Cereb. Blood Flow Metab. 22, 1170-1175.
36. Widenfalk, J., Lipson, A., Jubran, M., Hofstetter, C., Ebendal, T., Cao, Y., and Olson, L. (2003). Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience 120, 951-960. (Pubitemid 36966647)
37. Xue, M., and Del Bigio, M.R. (2001). Acute tissue damage after injections of thrombin and plasmin into rat striatum. Stroke 32, 2164-2169. (Pubitemid 32868117)
38. Zachary, I. (2001). Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am. J. Physiol. Cell Physiol. 280, C1375-C1386.
39. Zachary, I. (2003). VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochem. Soc. Trans. 31, 1171-1177.
40. Zachary, I. (2005). Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals 14, 207-221.